2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Neoplasms
19
Stomach Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Endometrial Neoplasms
13
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Oropharyngeal Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Mouth Neoplasms
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Interventions
fluorodopa F 18
4
Octreotide
4
Everolimus
4
Capecitabine
4
Temozolomide
3
Leucovorin
3
vatalanib
2
Trastuzumab
2
Oxaliplatin
2
Fluorouracil
2
Bortezomib
2
Bevacizumab
2
68Ga-NOTA-exendin-4
2
veliparib
1
tipifarnib
1
romidepsin
1
regorafenib
1
pentetreotide
1
pazopanib
1
pasireotide
1
motesanib diphosphate
1
cixutumumab
1
batifiban
1
Thalidomide
1
Surgical Procedures, Operative
1
Streptozocin
1
Sorafenib
1
Solutions
1
Salts
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulinoma
×
Observation
×
Clear all
NCT07272187
2025-12-09
EURAGIL
Herlev Hospital
Recruiting
138 enrolled